122 related articles for article (PubMed ID: 1899154)
1. Antimurine antibody to OKT3 in cardiac transplantation: implications for prophylaxis and retreatment of rejection.
O'Connell JB; Bristow MR; Hammond EH; Menlove RL; Ensley RD; Ratkovec RM; Renlund DG
Transplant Proc; 1991 Feb; 23(1 Pt 2):1157-9. PubMed ID: 1899154
[No Abstract] [Full Text] [Related]
2. Immunologic monitoring with Orthoclone OKT3 therapy.
Schroeder TJ; First MR; Hurtubise PE; Marmer DJ; Martin DM; Mansour ME; Melvin DB
J Heart Transplant; 1989; 8(5):371-80. PubMed ID: 2529358
[TBL] [Abstract][Full Text] [Related]
3. Sensitization to OKT3 monoclonal antibody in heart transplantation: correlation with early allograft loss.
O'Connell JB; Renlund DG; Hammond EH; Wittwer CT; Yowell RL; DeWitt CW; Jones KW; Gay WA; Menlove RL; Bristow MR
J Heart Lung Transplant; 1991; 10(2):217-21; discussion 221-2. PubMed ID: 1903303
[TBL] [Abstract][Full Text] [Related]
4. Overview of the development of Orthoclone OKT3: monoclonal antibody for therapeutic use in transplantation.
Goldstein G
Transplant Proc; 1987 Apr; 19(2 Suppl 1):1-6. PubMed ID: 3105134
[No Abstract] [Full Text] [Related]
5. Cardiac allograft cellular rejection during OKT3 prophylaxis in the absence of sensitization.
Moore CK; O'Connell JB; Renlund DG; Bristow MR; Hammond EH
Transplant Proc; 1991 Feb; 23(1 Pt 2):1055-8. PubMed ID: 1899151
[No Abstract] [Full Text] [Related]
6. Induction immunosuppression with OKT3 monoclonal antibody in cardiac transplant recipients.
Pulpón LA; Domínguez P; Cháfer M; Segovia J; Crespo MG; Pradas G; Burgos R; Figuera D
Transplant Proc; 1990 Oct; 22(5):2319. PubMed ID: 2120816
[No Abstract] [Full Text] [Related]
7. The incidence and quantity of antiidiotypic antibody formation after OKT3 monoclonal therapy in heart-transplant recipients.
Hesse CJ; Heyse P; Stolk BJ; Balk AH; Jutte NH; Mochtar B; Weimar W
Transplant Proc; 1990 Aug; 22(4):1772-3. PubMed ID: 2117805
[No Abstract] [Full Text] [Related]
8. Monoclonal versus polyclonal antibody therapy for prophylaxis against rejection after heart transplantation.
Kormos RL; Herlan DB; Armitage JM; Stein K; Kaufman C; Zeevi A; Duquesnoy R; Hardesty RL; Griffith BP
J Heart Transplant; 1990; 9(1):1-9, discussion 9-10. PubMed ID: 2107288
[TBL] [Abstract][Full Text] [Related]
9. Use of Orthoclone OKT3 monoclonal antibody in cardiac transplantation: early experience with rejection prophylaxis and treatment of refractory rejection.
Gilbert EM; Eiswirth CC; Renlund DG; Menlove RL; DeWitt CW; Freedman LA; Herrick CM; Gay WA; Bristow MR
Transplant Proc; 1987 Apr; 19(2 Suppl 1):45-53. PubMed ID: 3105140
[No Abstract] [Full Text] [Related]
10. First and second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection followed by testing for anti-OKT3 IgM and/or IgG immunization.
Birkeland SA; Bach JF; Chatenoud L; Jørgensen KA; Strate M; Elbirk A; Rohr N; Svendsen V
Transplant Proc; 1990 Feb; 22(1):221-2. PubMed ID: 2106740
[No Abstract] [Full Text] [Related]
11. Fibrinoid necrosis of a temporal artery complicating the treatment of refractory cardiac allograft rejection with murine monoclonal CD3 antibody (OKT3).
Hammond EH; Watson FS; Bristow MR; O'Connell JB; Gilbert EM; Doty DB; Renlund DG
J Heart Transplant; 1990; 9(3 Pt 1):236-8. PubMed ID: 2113090
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody OKT3 in cardiac and renal transplantation.
Norman DJ
Bibl Cardiol; 1988; (43):27-32. PubMed ID: 3147656
[No Abstract] [Full Text] [Related]
13. Successful retreatment of allograft rejection with OKT3.
First MR; Schroeder TJ; Hurtubise PE; Mansour ME; Penn I; Munda R; Balistreri WF; Alexander JW; Melvin DB; Fidler JP
Transplantation; 1989 Jan; 47(1):88-91. PubMed ID: 2521410
[TBL] [Abstract][Full Text] [Related]
14. Therapy of refractory, recurrent heart rejection with multiple courses of OKT3.
Frist WH; Gerhardt EB; Merrill WH; Atkinson JB; Eastburn TE; Stewart JR; Hammon JW; Bender HW
J Heart Transplant; 1990; 9(6):724-6. PubMed ID: 2126035
[TBL] [Abstract][Full Text] [Related]
15. Treatment of acute rejection with anti-T-cell antigen receptor complex alpha beta (T10B9.1A-31) or anti-CD3 (OKT3) monoclonal antibody: results of a prospective randomized double-blind trial.
Waid TH; Lucas BA; Thompson JS; Munch LC; Brown S; Kryscio R; Prebeck R; VanHoy MA; Jezek D
Transplant Proc; 1991 Feb; 23(1 Pt 2):1062-5. PubMed ID: 1899152
[No Abstract] [Full Text] [Related]
16. Review and preview of anti-T-cell antibodies.
Helderman JH
Transplant Proc; 1995 Oct; 27(5 Suppl 1):8-9. PubMed ID: 7482824
[No Abstract] [Full Text] [Related]
17. Reversing cardiac transplant rejection with Orthoclone OKT3.
Dault LA; Nagy CS; Collins JA
Am J Nurs; 1989 Jul; 89(7):953-5. PubMed ID: 2500020
[No Abstract] [Full Text] [Related]
18. Clinical experience with Muromonab-CD3 monoclonal antibody (OKT3) in heart transplantation.
Macris MP; Frazier OH; Lammermeier D; Radovancevic B; Duncan JM
J Heart Transplant; 1989; 8(4):281-7. PubMed ID: 2504894
[TBL] [Abstract][Full Text] [Related]
19. Orthoclone OKT3 monoclonal antibody reversal of hepatic and cardiac allograft rejection unresponsive to conventional immunosuppressive treatments.
Kremer AB; Barnes L; Hirsch RL; Goldstein G
Transplant Proc; 1987 Apr; 19(2 Suppl 1):54-7. PubMed ID: 3105141
[No Abstract] [Full Text] [Related]
20. OKT3 antibody response study: comparative testing of human antimouse antibody.
Kimball JA; Norman DJ; Shield CF; Schroeder TJ; Lisi P; Garovoy M; O'Connell JB; Stuart F; McDiarmid SV; Wall W
Transplant Proc; 1993 Apr; 25(2 Suppl 1):74-6. PubMed ID: 8465432
[No Abstract] [Full Text] [Related]
[Next] [New Search]